TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Celularity ( (CELU) ) has shared an announcement.
On September 2, 2025, Nasdaq informed Celularity Inc. that the company is in compliance with Listing Rule 5250(c)(1), following the filing of its Form 10-Q for the periods ending March 31, 2025, and June 30, 2025. This resolution closes the matter, indicating that Celularity has met the necessary regulatory requirements, which may positively impact its market standing and reassure stakeholders.
The most recent analyst rating on (CELU) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Celularity stock, see the CELU Stock Forecast page.
Spark’s Take on CELU Stock
According to Spark, TipRanks’ AI Analyst, CELU is a Neutral.
Celularity’s stock score is primarily influenced by its financial performance, which shows strong revenue growth but significant profitability challenges. The recent corporate event of selling IP to reduce debt is a positive step towards financial stability. However, technical indicators suggest caution due to potential bearish momentum and high volatility. The valuation remains a concern due to ongoing losses.
To see Spark’s full report on CELU stock, click here.
More about Celularity
Average Trading Volume: 252,903
Technical Sentiment Signal: Buy
Current Market Cap: $105.2M
For detailed information about CELU stock, go to TipRanks’ Stock Analysis page.